Help us: Donate
Follow us on:
×

Shift Bioscience

Banner

Organization Description

 

Shift Bioscience claims to have identified safer drug targets for cellular rejuvenation by applying machine-learning ‘driver’ clocks to cell reprogramming. The company says that it is on the cusp of validating these targets and is uniquely positioned to do so.

Team

Daniel Ives, Ph.D.

Shift Bioscience - Founder and CEO

Want the latest longevity news? Subscribe to our Newsletter!